Keyword: European Medicines Agency
The European Medicines Agency has begun laying the foundation for its new Amsterdam headquarters, aiming to finish construction by November 2019.
The EMA has mapped out a path to approval for Auris’ acute hearing loss treatment after the drug failed in phase 3 late last year.
The proposal jibes with the wishes of the biopharma industry, but it remains to be seen whether the European Union is receptive to the idea.
The precipitous drop in the amount of space available to the EMA will force the agency to hold meetings off-site.
Adhesys Medical, a surgical adhesive company, said it has received a CE mark for its Mar-Cutis Flix topical skin adhesive for surgical use.
After tying with Milan in a third round of voting, Amsterdam will be the new home of the European Medicines Agency.
The U.K. government announced that former GlaxoSmithKline chief Sir Andrew Witty will head up new pathway to get med and tech onto the market quicker.
The EMA’s call for extra staff comes as it is bracing itself for the likely loss of employees when it moves from its current home in London.
EMA sounded the alarm after a staff survey found as few as 6% of its staff would move to some of the 19 cities vying to host it when it leaves London.
The spectacular rehabilitation of Aveo's cancer drug tivozanib continues with E.U. approval as a treatment for advanced kidney cancer.